-
NYU Dataset
Timed instrumental activities of daily living in multiple sclerosis: The test of everyday cognitive ability (TECA)
- Authors
- Leigh E. CharvetMichael T. ShawKathleen ShermanShannon Haas1 more author(s)...
- Description
This dataset was compiled as part of the development of the Test of Everyday Cognitive Ability (TECA), a test of ten Timed Instrumental Activities of Daily Living (TIADLS) meant to measure a broad ranger or functioning. TECA’s performance was tested on 177 patients with MS and compared to healthy controls (49 subjects). Participants were recruited from the outpatient practices at Stony Brook Medicine’s...
- Subject
-
Chronic DiseaseMental Health
- Access Rights
- Application RequiredAuthor Approval Required
-
NYU Dataset
Brief Computer-Based Information Processing Measures and Pediatric-Onset Multiple Sclerosis
- Authors
- Elizabeth BartlettMichael T. ShawColleen SchwarzCharles Feinberg3 more author(s)...
- Description
This data was collected as part of a study of Pediatric-Onset Multiple Sclerosis (POMS), and to define the neuroanatomic underpinnings of deficits identified with cognitive screening batteries in POMS. Participants with POMS (n=15) were recruited through outpatients visits at the Lourie Center for Pediatric MS at Stony Brook University Health Center, and healthy controls (n=21) were recruited through...
- Subject
-
Chronic DiseaseMental Health
- Access Rights
- Application RequiredAuthor Approval Required
-
NYU Dataset
Demographic, lesion pattern, and lesion location data for multiple sclerosis patients
- Authors
- Sanjeev ChawlaIlya KisterTim SinneckerJens Querfel3 more author(s)...
- Description
This dataset was compiled as part of an exploratory study to determine the longitudinal changes in multiple sclerosis (MS) lesions over time on ultra-high field MR imaging. Nine patients with MS underwent high-resolution 3D-susceptibility weighted imaging (SWI) and 2D-gradient-echo-T2*-weighted imaging on 7T MRI at baseline and after approximately 2.4 years for follow-up imaging. The data includes...
- Subject
-
Chronic DiseaseHealth StatusPopulation Characteristics
- Access Rights
- Free to All
-
NYU Dataset
Longitudinal study of immunity to SARS‐CoV2 in ocrelizumab‐treated MS patients up to 2 years after COVID‐19 vaccination
- Alternate Title(s)
- Vaccine‐generated Immunity in Ocrelizumab‐treated Patients: Longitudinal Assessments (VIOLA)
- Authors
- Ilya KisterRyan CurtinAmanda L. PiquetTyler Borko16 more author(s)...
- Description
This is a prospective, two-year study of immunity against SARS-CoV-2 in multiple sclerosis patients receiving ocrelizumab (OCR) at the time of COVID vaccination. Researchers recruited 60 patients (aged 18-65) from the NYU MS Comprehensive Care Center in New York City and the Rocky Mountain MS Center at the University of Colorado Anschutz Medical Center in Aurora, CO. Participants provided blood samples...
- Subject
-
Chronic DiseaseCOVID-19
- Access Rights
- Free to All